Applied Genetic Technologies Corporation (AGTC)
(Delayed Data from NSDQ)
$4.30 USD
-0.04 (-0.92%)
Updated May 3, 2019 04:13 PM ET
After-Market: $4.40 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[AGTC]
Reports for Purchase
Showing records 1 - 20 ( 364 total )
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
It''s the Final Countdown...To Going Private
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Sights Set On a New Chapter; Syncona to Acquire AGTC; Downgrade to Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Biomedical and Genetics
A Tale of Two Risks; AGTC-501 Remains Best- In-Class for XLRP as Market Dynamic Plays Out
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Biomedical and Genetics
FY22 Results; XLRP Best-In-Class Status Continues As Financing Options Weighed; Target Adjusted to $16
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Time to Step Up for These Catalysts; Making Real Differences
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Biomedical and Genetics
AGTC-501 Primed For Key Readouts as Profile Continues to Differentiate From Competitors
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Biomedical and Genetics
Positive FDA Feedback Blesses Manufacturing Facility''s Design and SOP; On Track to Be Operational in 4Q22
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
At ASRS 2022, AGTC gave multiple presentations of data from its AAV-based gene therapy programs in X-linked retinitis pigmentosa
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
MGT009 Data Still Leave Us Wanting; Why We Believe AGTC-501 Remains Leader
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Biomedical and Genetics
Healthcare Coverage Update - Dropping Coverage
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
1Q2022 - Cash Balance and Upcoming Catalysts For Our Biotech Coverage Universe
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z